Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingswood H. Regulatory News (KWG)

  • There is currently no data for KWG

Convertible preference share issue

31 Dec 2021 09:40

RNS Number : 1769X
Kingswood Holdings Limited
31 December 2021
 

 

KINGSWOOD HOLDINGS LIMITED

("Kingswood", the "Company" or the "Group")

Convertible preference share issue

Kingswood announces a further £29.6 million convertible preference share issue to funds managed and/or advised by Pollen Street Capital

Brings total equity issued under subscription facility to £77.4 million of the £80 million committed

Funds to be used to further accelerate acquisitive growth strategy

 

Kingswood Holdings Limited (AIM: KWG), the international, vertically integrated wealth and investment management group, is pleased to announce it has issued a further 29,600,000 new convertible preference shares (the "New Convertible Preference Shares"), under the terms of its convertible preference share subscription agreement with HSQ INVESTMENT LIMITED (the "Subscription Agreement") originally announced on 12 September 2019. HSQ INVESTMENT LIMITED is a wholly owned indirect subsidiary of funds managed and/or advised by Pollen Street Capital Limited ("Pollen Street").

The New Convertible Preference Shares represent the twelfth tranche of irredeemable convertible preference shares issued pursuant to the Subscription Agreement and as such the total number of irredeemable Convertible Preference Shares held by Pollen Street has increased to 77,428,443 shares, at an issue price of £1 each. This is expected to be the final drawdown under the Subscription Agreement.

Variation to terms of Subscription Agreement

Under the terms of the Subscription Agreement, Kingswood agreed that, in consideration for the committed investment, Pollen Street will be entitled to sale proceeds equivalent to at least twice the amount it has subscribed for the Convertible Preference Shares. For the twelfth and any subsequent tranche of irredeemable convertible preference shares issued, Pollen Street will be entitled to sale proceeds equivalent to at least one and a half times the amount it has subscribed for those Convertible Preference Shares.

The amendment of the terms of the Subscription Agreement entered into by the Company and Pollen Street is considered to be a Related Party Transaction by virtue of Howard Garland and Lindsey McMurray's positions at Pollen Street. As such, the Directors of the Company (excluding Howard Garland and Lindsey McMurray) consider, having consulted with finnCap Ltd, the Company's Nominated Adviser, that the terms of the amendment to the Subscription Agreement are fair and reasonable insofar as the Shareholders are concerned.

Gary Wilder, Group CEO at Kingswood commented: "We are thrilled to have Pollen Street's capital support through the convertible preference facility and this new issue further solidifies our balance sheet by an additional £29.6 million as we accelerate the next stage of our growth journey. We remain committed to our growth strategy within the UK and internationally. We have signed four acquisitions in 2021 and have a strong pipeline of high-quality UK opportunities under negotiation, four of which are in the exclusive due diligence stage.

We have a strong and dynamic leadership team with large firm financial services experience and successful track records which combined with our strong risk and compliance culture places us in a unique position to effectively execute our strategy".

Howard Garland, Partner at Pollen Street said: "We continue to believe the wealth management sector offers compelling opportunities for growth. Kingswood has a clear strategy, and we are excited to partner with them to deliver these goals. Pollen Street has extensive expertise in the global financial services sector, growing market leading companies organically and through acquisition. We believe our unique experience and skillset coupled with our capital commitment will enable Kingswood to continue to successfully execute its growth strategy."

 

For further details, please contact:

Kingswood Holdings Limited

+44 (0)20 7293 0730

David Lawrence

www.kingswood-group.com

finnCap Ltd (Nomad & Broker)

+44 (0)20 7220 0500

Simon Hicks / Abigail Kelly

 

GreenTarget (for Kingswood media)

Jamie Brownlee / Alice Gasson / Ellie Basle 

+44 (0)20 7324 5498

Jamie.Brownlee@greentarget.co.uk

Stand Agency (for Pollen Street media)

Cait Dacey

 

+44 (0) 7973 596 503

pollenstreet@standagency.com

About Kingswood

Kingswood Holdings Limited (trading as Kingswood) is an AIM-listed (AIM: KWG) international fully integrated wealth management group with circa £7.8 billion of Assets under Advice and Management. It services circa 8600 clients from a growing network of offices in the UK including Abingdon, Beverley, Darlington, Derby, Grimsby, Harrogate, Hull, Lincoln, London, Maidstone, Newcastle, Sheffield (2), Worcester and York with overseas offices in Johannesburg, South Africa and Atlanta, New York and San Diego in US.

Kingswood offers a range of trusted investment solutions to its clients, which range from private individuals to some of the UK's largest universities and institutions, including investment advice and management, personal and company pensions and wealth planning. Kingswood is focused on becoming a leading player in the wealth and investment management market through targeted acquisitions in the UK and US, creating a global business through strategic partnerships.

About Pollen Street Capital

Pollen Street is an independent alternative investment management company, focused on accelerating the progress of the financial, business services and technology sectors. It was established in 2013 and manages over £3bn AUM across private equity and credit strategies on behalf of investors including leading public and corporate pension funds, insurance companies, Sovereign Wealth Funds, Endowment and Foundations, asset managers, banks, and family offices from around the world. Pollen Street has a team of over 70 professionals with offices in London and New York City. www.pollencap.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONDKDBNCBDKABN
Date   Source Headline
2nd Aug 20187:00 amRNSSUBSCRIPTION AND ISSUE OF EQUITY
1st Aug 201811:40 amRNSDirector/PDMR Shareholding
29th Jun 20187:00 amRNSBoard Appointment
29th Jun 20187:00 amRNSResults for the financial year ended 31 Dec 2017
18th Jun 20187:00 amRNSDirectorate Change
7th Jun 20187:00 amRNSAcquisition Update
30th May 201812:00 pmRNSIssue of Equity and Director/PDMR Shareholding
29th May 201812:00 pmRNSConversion Update
23rd May 20182:16 pmRNSAcquisition Update
18th May 20181:03 pmRNSAcquisition and Trading Update
19th Feb 201811:01 amRNSBoard Appointment
29th Jan 20182:30 pmRNSResult of EGM
16th Jan 20187:00 amRNSPosting of Circular and Notice of EGM
21st Dec 20177:00 amRNSResignation of Director
12th Dec 20177:00 amRNSSyndicated Facilities Agreement
5th Dec 20171:20 pmRNSDirector/PDMR Shareholding and Issue of Equity
16th Nov 20172:00 pmRNSFurther re Funding
7th Nov 20177:00 amRNSAcquisition of Newbridge and Funding
23rd Oct 20177:00 amRNSDirectorate Change
17th Oct 20177:00 amRNSIssue of Equity
10th Oct 20174:43 pmRNSProposed Acquisition and Financing
22nd Sep 20172:05 pmRNSIssue of Equity
20th Sep 201712:45 pmRNSResult of AGM
20th Sep 20177:00 amRNSUpdate in relation to the Board
18th Sep 20177:00 amRNSUnaudited interims for six months to 30 June 2017
13th Sep 201711:00 amRNSUpdate in relation to the Board
6th Sep 20178:00 amRNSHolding(s) in Company
1st Sep 20177:00 amRNSHolding(s) in Company
21st Aug 20174:33 pmRNSHolding(s) in Company
9th Aug 20175:05 pmRNSHolding(s) in Company
3rd Aug 20174:16 pmRNSHolding(s) in Company
3rd Aug 20171:58 pmRNSHolding(s) in Company
3rd Aug 20171:54 pmRNSHolding(s) in Company
26th Jul 20174:40 pmRNSUpdate on Admission
19th Jul 20174:24 pmRNSResult of EGM, Result of Open Offer and Update
26th Jun 20175:20 pmRNSNotice of EGM and Posting of Circular
26th Jun 20173:25 pmRNSDirectorate Change
23rd Jun 20177:01 amRNSSubscription and Open Offer
23rd Jun 20177:00 amRNSFinal Results
8th Jun 201710:28 amRNSBridge Financing and Convertible Loan Stock Update
25th May 20177:00 amRNSCLS Update and Proposed Re-Financing
27th Mar 20177:00 amRNSLoan Facility
27th Feb 20177:00 amRNSIssue of Equity
10th Feb 20177:00 amRNSTrading Update
17th Jan 20177:00 amRNSIssue of Equity
18th Oct 20167:00 amRNSChange of Adviser
7th Oct 201611:18 amRNSRESULTS OF FUNDRAISING AND DIRECTORS' DEALINGS
7th Oct 20167:00 amRNSPROPOSED ACQUISITION OF CERTAIN ASSETS OF TOWRY AM
14th Sep 20167:00 amRNSDirector Dealing
13th Sep 20167:00 amRNSAcquisition & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.